Alphafetoprotein in screening for congenital hypothyroidism

Area of Science:

• Biochemistry
• Neonatal Medicine
• Endocrinology

Background:

• Congenital hypothyroidism (CH) requires early detection for proper neurodevelopment.
• Current screening methods may benefit from additional sensitive biomarkers.
• Alphafetoprotein (AFP) is a protein with potential roles in neonatal development.

Purpose of the Study:

• To evaluate alphafetoprotein (AFP) as a sensitive indicator for congenital hypothyroidism (CH).
• To assess the relationship between AFP levels and thyroid function in neonates and CH patients.
• To determine AFP's utility as a screening and follow-up tool for CH.

Main Methods:

• Study included 500 full-term neonates and 25 patients with congenital hypothyroidism.
• Measured AFP, thyroid stimulating hormone (TSH), and thyroxine (T4) levels.
• Analyzed relationships between AFP, TSH, T4, and patient age.

Main Results:

• Two neonates presented with elevated AFP; one had persistent CH markers, the other transient hypothyroidism.
• Mean AFP levels were significantly higher in new CH patients compared to previously diagnosed CH patients and controls.
• Significant correlations were observed between AFP and T4, AFP and TSH, and AFP and age.

Conclusions:

• AFP is a sensitive indicator of thyroid status in neonates.
• AFP can be utilized as an early screening test for hypothyroidism from birth.
• AFP aids in the ongoing monitoring and follow-up of patients with congenital hypothyroidism.